» Articles » PMID: 6589638

Enhanced Expression of the Human Gene N-myc Consequent to Amplification of DNA May Contribute to Malignant Progression of Neuroblastoma

Overview
Specialty Science
Date 1984 Aug 1
PMID 6589638
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies had revealed that DNA with partial similarity to the myc oncogene (N-myc) is frequently amplified in human neuroblastoma cell lines and neuroblastoma tumors. We show here for one patient that N-myc amplification is confined to the neuroblastoma tumor and is not present in normal tissue. N-myc mRNA approximately equal to 4.0 kilobases in size is detectable in neuroblastoma cell lines and tumors and in a retinoblastoma cell line. By contrast, appreciable amounts of this RNA were not present in a number of cell lines derived from other human tumors and in fibroblasts from a normal individual and from a neuroblastoma patient. Low levels of N-myc RNA were found in human and murine neuroblastoma cell lines lacking amplification of this gene, up to 80-fold greater levels in all cell lines carrying amplified N-myc. In situ hybridization to sections of neuroblastoma tumors revealed high expression of N-myc predominantly in undifferentiated neuroblasts. We hypothesize that amplification and consequent elevated expression of N-myc may be related to malignant progression.

Citing Articles

Loss of ARID1A leads to a cold tumor phenotype via suppression of IFNγ signaling.

Watson P, DeVaux C, Freeman K Sci Rep. 2025; 15(1):8716.

PMID: 40082458 PMC: 11906763. DOI: 10.1038/s41598-025-91688-4.


The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres.

Graham M, Xu B, Davis C, Meeker A, Heaphy C, Yegnasubramanian S Cancer Res Commun. 2024; 4(6):1533-1547.

PMID: 38837897 PMC: 11188873. DOI: 10.1158/2767-9764.CRC-22-0287.


Inhibition of OCT4 binding at the locus induces neuroblastoma cell death accompanied by downregulation of transcripts with high-open reading frame dominance.

Nakatani K, Kogashi H, Miyamoto T, Setoguchi T, Sakuma T, Kugou K Front Oncol. 2024; 14:1237378.

PMID: 38390263 PMC: 10882222. DOI: 10.3389/fonc.2024.1237378.


Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.

Pusch F, Dorado Garcia H, Xu R, Gurgen D, Bei Y, Bruckner L Mol Cancer Ther. 2023; 23(4):507-519.

PMID: 38159110 PMC: 10985474. DOI: 10.1158/1535-7163.MCT-23-0094.


Metastasis in neuroblastoma: the question.

Bhavsar S Front Oncol. 2023; 13:1196861.

PMID: 37274289 PMC: 10233040. DOI: 10.3389/fonc.2023.1196861.


References
1.
Levan A, MANOLOV G, Clifford P . Chromosomes of a human neuroblastoma: a new case with accessory minute chromosomes. J Natl Cancer Inst. 1968; 41(6):1377-87. View

2.
Cox D, YUNCKEN C, Spriggs A . MINUTE CHROMATIN BODIES IN MALIGNANT TUMOURS OF CHILDHOOD. Lancet. 1965; 1(7402):55-8. DOI: 10.1016/s0140-6736(65)90131-5. View

3.
Biedler J, Spengler B . Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science. 1976; 191(4223):185-7. DOI: 10.1126/science.942798. View

4.
Balaban-Malenbaum G, Gilbert F . Double minute chromosomes and the homogeneously staining regions in chromosomes of a human neuroblastoma cell line. Science. 1977; 198(4318):739-41. DOI: 10.1126/science.71759. View

5.
Schimke R, Kaufman R, Alt F, Kellems R . Gene amplification and drug resistance in cultured murine cells. Science. 1978; 202(4372):1051-5. DOI: 10.1126/science.715457. View